Saturday, 31 October 2026European Markets

HEIJMANS Stock Bullish Momentum With A 9.26% Rise On Thursday

Loading stream...

(VIANEWS) - The Market ended the session with HEIJMANS (HEIJM.AS) jumping 9.26% to €23.05 on Thursday, following the last session's upward trend. AEX-Index fell 0.38% to €936.06, following the last session's upward trend on what was a somewhat down trend trading session today.

HEIJMANS's last close was €21.10, 2.76% below its 52-week high of €21.70.

About HEIJMANS

Koninklijke Heijmans N.V. engages in the property development, construction, and infrastructure businesses in the Netherlands and internationally. The company focuses on the development of large and smaller-scale projects in urban and out-of-town areas, as well as acts as an initiator, developer, and seller of residential properties. It also engages in building homes; and the restoration, redevelopment, renovation, maintenance, and service of existing housing stock. In addition, the company designs, realizes, and maintains electro-technical and mechanical installations; and realizes large-scale and complex construction contracts in the customer and market segments of health care, government and semi-government organizations, commercial property, the high-tech clean industry, and datacenters, as well as provides management and maintenance services. Further, it focuses on the construction, enhancement, and maintenance of road infrastructure and public spaces, including related installations and on-site objects. The company was formerly known as Heijmans N.V. and changed its name to Koninklijke Heijmans N.V. in September 2023. Koninklijke Heijmans N.V. was founded in 1923 and is headquartered in Rosmalen, the Netherlands.

Earnings Per Share

As for profitability, HEIJMANS has a trailing twelve months EPS of €2.39.

PE Ratio

HEIJMANS has a trailing twelve months price to earnings ratio of 9.64. Meaning, the purchaser of the share is investing €9.64 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.05%.

More news about HEIJMANS (HEIJM.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com